Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 24, 2006

View Archived Issues

Synergy seen with AT-001 and hydroxychloroquine in rheumatoid arthritis

Sitaxsentan ameliorates effects of cardioplegic arrest and cardiopulmonary bypass

Targeting Kv1.3 channels shows promise for treating autoimmune diseases

Mistletoe extract demonstrates antiangiogenic and proapoptotic activity in preclinical studies

Cardiome Pharma advances vernakalant development in third quarter

CP-690550 improves signs and symptoms of rheumatoid arthritis

Crucell completes acquisition of SBL Vaccin

Final patient treated in EDEMA3 study of DX-88 for HAE

Phase I/II study investigates Imprime PGG with G-CSF for stem cell mobilization

Contracts issued for prepandemic influenza vaccines

Synthetic human secretin improves magnetic resonance cholangiopancreatography

Study shows lenalidomide has a role in treating relapsed/refractory multiple myeloma

Novel melanocortin agonist shows efficacy in animal models of acute renal failure

Preclinical and clinical efficacy of different antiangiogenic strategies for the management of CNV

European orphan drug status for Removab antibody in gastric cancer

Galapagos and CFFT extend cystic fibrosis alliance

Nventa advances development of HspE7 following FDA meeting

ExonHit identifies companion diagnostic to assist EHT-0202 development

Cellegy's stockholders approve asset sale to ProStrakan

Betaferon approved in Australia for earliest stages of MS

Arcoxia shows similar rates of adverse cardiovascular events to diclofenac

Apricitabine has no significant adverse effect on cardiac safety

Draximage to run neuroblastoma trials of I-131 MIBG

Recent Shionogi patent discloses novel therapeutic option for HIV infection

Novel agents for dermatological disorders disclosed in recent Pfizer patent

Recent Novartis and Sankyo patents describe new treatment options for cardiovascular diseases

Gardasil available in France

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 18, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 18, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Maintenance, man: Lilly’s phase III weight trial hits goals
BioWorld
Eli Lilly and Co. took another step toward adding a way for patients to hang onto their weight loss when the firm disclosed positive top-line data from the phase...
AI drug developer Insilico to raise $292 million in Hong Kong IPO
BioWorld
Insilico Medicine Inc. plans to raise HK$2.27 billion (US$292 million) in its IPO on the Hong Kong Securities Exchange to advance its clinical pipeline and invest...